Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-260,232
Closed -$31.3M 1071
2025
Q2
$31.3M Sell
260,232
-3,973
-2% -$444K 0.09% 198
2025
Q1
$32.3M Sell
264,205
-6,624
-2% -$839K 0.11% 190
2024
Q4
$34.4M Buy
+270,829
New +$31.3M 0.1% 193
2017
Q2
Sell
-2,900
Closed -$255K 1313
2017
Q1
$255K Hold
2,900
﹤0.01% 1188
2016
Q4
$249K Buy
+2,900
New +$237K ﹤0.01% 1176

Other funds holding JBTM

Axa's JBTM Position: Q3 2025 in Review

Axa sold out of JBT Marel (JBTM) in Q3 2025, closing a stake of 260,232 shares — an estimated $31.3M sold.

Axa first reported a position in JBTM in Q4 2016 and held it in 5 quarters. The position peaked at $34.4M in Q4 2024. 372 funds tracked by Wall St. Rank hold JBTM as of Q3 2025.

  • Axa reported no remaining JBT Marel position as of Q3 2025 after selling out during the quarter.
  • Axa sold 260,232 JBT Marel shares in Q3 2025, an estimated $31.3M.
  • Axa first reported a position in JBT Marel in Q4 2016 and held it in 5 quarters.
  • Axa's JBT Marel position peaked at $34.4M in Q4 2024.
  • 372 funds tracked by Wall St. Rank held JBT Marel as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.